NCT07175220 2025-11-18
Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Recruiting
Clinical Trials
7 trialsNCT04699968 2023-06-07
A Trial of SHR-1701 With or Without Famitinib in Patients With Advanced or Metastatic NSCLC
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Withdrawn
NCT04580498 2023-05-19
A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT05177497 2022-01-04
SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC
Shanghai Chest Hospital
Phase 2 Unknown
NCT05132413 2021-11-24
A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3 Unknown
NCT04884009 2021-05-12
A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT04560244 2020-09-23
A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line Treatment
Shandong Cancer Hospital and Institute
Phase 2 Unknown